PATENT CLAIM ANALYSIS

Application Number: 16161642
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "230500"]

Abstract:
The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

Claim (Index 1):
A method of treating a disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound having the formula: wherein\n R 1  is selected from the group consisting of pyridine and thiazole, optionally substituted with 1-4 groups each independently selected from R 1a ; \n each R 1a  is independently selected from the group consisting of hydrogen, C 1-6  alkyl, halogen, C 1-6  haloalkyl, C 1-6  alkoxy, C 1-6  haloalkoxy, N-oxide, and C 3-8  cycloalkyl; \n ring J is selected from the group consisting of phenyl, pyridine, pyrazole, and triazole; \n each R 2  is independently selected from the group consisting of hydrogen, C 1-6  alkyl, halogen, C 1-6  haloalkyl, and \u2014CN; \n R 3a  is F; \n subscript n is an integer from 0 to 3; \n or salts and isomers thereof, \n thereby treating the disorder.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14549885', '15889494', '15621013', '15013218', '14487347']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7883340318167283
- 35 USC 102 Novelty (BERT): 0.6620831509608829
- Combined Prediction Score: 0.7757089437311437
- Mean Citation Score: 545.721512
- Max Citation Score: 671.1336
- Similarity Product: 610.2746429895401

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test